Booz Allen Hamilton Holding Corp BAH
Booz Allen Hamilton Holding Corporation (herein referred to as "Booz Allen," the "Company," "we," "us," or "our") is an advanced technology company building products and solutions for government and business. For more than 112 years, Booz Allen has evolved to meet the needs of commercial, international, and government customers. After September 11th, 2001, the Company undertook a fundamental transformation when it expanded into critical and sensitive national security missions. Our teams began delivering mission impact, executing full-spectrum cyber operations, helping the U.S. military counter the threat of improvised explosive devices ("IEDs"), standing up counter-terrorism fusion centers, and supporting intelligence missions. This work helped lay the foundation for the Company's national security portfolio and strengthened its credibility in highly complex missions. In 2008, a strategic business decision was made to prioritize and protect the Company's government and national security interests and spin off its global commercial business.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.22B | $11.98B | $10.66B | $9.26B | $8.36B | $7.86B | $7.46B | $6.70B | $6.17B | $5.81B |
| Cost of revenue | $5.30B | $5.42B | $4.92B | $4.30B | $3.90B | $3.66B | $3.38B | $3.10B | $2.87B | $2.68B |
| Gross profit | $5.91B | $6.56B | $5.74B | $4.95B | $4.46B | $4.20B | $4.08B | $3.60B | $3.30B | $3.13B |
| SG&A | $1.27B | $1.25B | $1.28B | $1.53B | $1.16B | $1.04B | $1.04B | $927.9M | $855.5M | $814.1M |
| Total operating expenses | $10.18B | $10.61B | $9.65B | $8.81B | $7.68B | $7.10B | $6.79B | $6.10B | $5.65B | $5.30B |
| Operating income | $1.03B | $1.37B | $1.01B | $447.0M | $685.2M | $754.4M | $669.2M | $602.4M | $519.7M | $506.0M |
| Interest expense | — | — | $172.9M | $119.8M | $92.4M | $81.3M | $97.0M | $89.5M | $82.3M | $62.3M |
| Pre-tax income | $862.0M | $1.22B | $854.0M | $368.0M | $604.0M | $662.4M | $579.4M | $515.4M | $430.0M | $425.7M |
| Income tax | $11.0M | $284.0M | $248.0M | $97.0M | $137.5M | $53.5M | $96.8M | $96.9M | $128.3M | $164.8M |
| Net income | $850.5M | $935.0M | $605.7M | $271.2M | $466.6M | $609.0M | $482.6M | $418.5M | $301.7M | $260.8M |
| EPS, basic | 6.92 | 7.28 | 4.61 | 2.04 | 3.46 | 4.40 | 3.43 | 2.94 | 2.05 | 1.74 |
| EPS, diluted | 6.90 | 7.25 | 4.59 | 2.03 | 3.44 | 4.37 | 3.41 | 2.91 | 2.03 | 1.72 |
| Shares, diluted (wtd. avg.) | $122.4M | $128.3M | $130.8M | $132.7M | $134.9M | $138.7M | $141.2M | $143.2M | $147.8M | $150.3M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $728.0M | $885.0M | $554.0M | $405.0M | $696.0M | $991.0M | $741.9M | $284.0M | $287.0M | $217.4M |
| Receivables | $2.06B | $2.27B | $2.05B | $1.77B | $1.62B | $1.41B | $1.46B | $1.33B | $1.13B | $991.8M |
| Total current assets | $2.96B | $3.31B | $2.74B | $2.29B | $2.45B | $2.64B | $2.33B | $1.70B | $1.49B | $1.29B |
| Property, plant and equipment | $171.0M | $177.0M | $188.0M | $195.2M | $202.2M | $204.6M | $208.1M | $172.5M | $152.4M | $139.2M |
| Goodwill | $61.0M | $2.40B | $2.34B | $2.34B | $2.02B | $1.58B | $1.58B | $1.58B | $1.58B | $1.57B |
| Other intangibles | $509.0M | $563.0M | $601.0M | $685.6M | $646.7M | $307.1M | $301.0M | $287.1M | $278.5M | $271.9M |
| Total assets | $7.12B | $7.31B | $6.56B | $6.55B | $6.03B | $5.50B | $4.79B | $3.83B | $3.61B | $3.37B |
| Accounts payable | $909.0M | $987.0M | $1.05B | $1.32B | $902.6M | $667.0M | $698.0M | $664.9M | $557.6M | $504.1M |
| Short-term debt | $19.0M | $83.0M | $62.0M | $41.2M | $68.4M | $77.9M | $177.9M | $57.9M | $63.1M | $193.2M |
| Total current liabilities | $1.66B | $1.85B | $1.69B | $1.90B | $1.53B | $1.29B | $1.33B | $1.18B | $1.03B | $1.10B |
| Long-term debt | $3.92B | $3.92B | $3.35B | $2.77B | $2.73B | $2.28B | $2.01B | $1.70B | $1.76B | $1.47B |
| Total liabilities | $6.01B | $6.31B | $5.52B | $5.56B | $4.98B | $4.43B | $3.94B | $3.16B | $3.04B | $2.80B |
| Retained earnings | $3.64B | $3.07B | $2.40B | $2.05B | $2.02B | $1.76B | $1.33B | $994.8M | $690.5M | $478.1M |
| Total equity | $1.10B | $1.00B | $1.05B | $992.0M | $1.05B | $1.07B | $856.4M | $675.4M | $562.5M | $584.9M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.04B | $1.01B | $259.0M | $603.0M | $736.5M | $718.7M | $551.4M | $499.6M | $369.1M | $382.3M |
| Depreciation and amortisation | $163.0M | $165.0M | $164.0M | $165.0M | $145.7M | $84.3M | $81.1M | $68.6M | $64.8M | $59.5M |
| Stock-based compensation | $69.0M | $94.0M | $95.0M | $80.0M | $69.8M | $59.8M | $43.3M | $31.3M | $23.3M | $21.2M |
| Capital expenditure | $90.0M | $98.0M | $67.0M | $76.0M | $80.0M | $87.2M | $128.1M | $94.7M | $78.4M | $53.9M |
| Investing cash flow | -$300.0M | -$218.0M | -$91.0M | -$468.0M | -$867.7M | -$158.3M | -$128.1M | -$89.2M | -$96.5M | -$300.9M |
| Financing cash flow | -$898.0M | -$460.0M | -$19.0M | -$426.0M | -$163.8M | -$311.3M | $34.6M | -$413.4M | -$203.1M | -$51.5M |
| Dividends paid | $276.0M | $268.0M | $254.0M | $236.0M | $209.1M | $181.1M | $146.6M | $114.2M | $103.4M | $92.9M |
| Buybacks | $598.0M | $812.0M | $404.0M | $224.0M | $418.9M | $313.4M | $182.2M | $252.8M | $270.3M | $46.5M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001443646-26-000021.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| G | Genpact LTD | $6.27B | 11.9x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.19B | 18.4x | 2.4% |
| EXPO | EXPONENT INC | $3.25B | 33.0x | 4.2% |
| HURN | Huron Consulting Group Inc. | $2.52B | 26.6x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.14B | 83.6x | 56.4% |
| ICFI | ICF International, Inc. | $1.58B | 17.8x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $735.5M | 58.1x | 14.9% |
| ONT | Onterris, Inc. | $626.8M | — | 19.3% |